BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9121238)

  • 21. Pneumococcal resistance in perspective: how well are we combating it?
    Amsden GW
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S125-8. PubMed ID: 14770075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new antibiotic against respiratory tract infections. More power against pneumococci].
    MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
    [No Abstract]   [Full Text] [Related]  

  • 24. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Hutchinson J
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12102064
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pneumococcal infections: penicillin resistance and therapeutic implications].
    Kamoun A; Ben Hassen A; Mahjoubi F; Ben Redjeb S
    Tunis Med; 1995 Feb; 73(2):119-23. PubMed ID: 9506153
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibiotic resistance of Streptococcus pneumoniae (Pneumococcus). Epidemiologic and clinical aspects].
    Kaufhold A
    Med Klin (Munich); 1988 Oct; 83(21):723-6. PubMed ID: 3070311
    [No Abstract]   [Full Text] [Related]  

  • 27. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae: an emerging microbial threat.
    Leggiadro RJ
    Pediatrics; 1994 Mar; 93(3):500-3. PubMed ID: 8115213
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of invasive pneumococcal disease in Kumasi, Ghana.
    Holliman RE; Liddy H; Johnson JD; Adjei O
    Trans R Soc Trop Med Hyg; 2007 Apr; 101(4):405-13. PubMed ID: 17126867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
    Ferrara AM
    Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
    Nuermberger EL; Bishai WR
    Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
    Fuller JD; Low DE
    Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Infections with drug resistant bacteria and their treatment methods--PRSP infections].
    Kuroki H
    Rinsho Byori; 2000 Jan; Suppl 111():125-31. PubMed ID: 10804802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention.
    Harwell JI; Brown RB
    Chest; 2000 Feb; 117(2):530-41. PubMed ID: 10669700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease.
    Cockeran R; Anderson R; Feldman C
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shanghai, China.
    Zhao GM; Black S; Shinefield H; Wang CQ; Zhang YH; Lin YZ; Lu JL; Guo YF; Jiang QW
    Pediatr Infect Dis J; 2003 Aug; 22(8):739-42. PubMed ID: 12913778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Empyema due to erythromycin-resistant Pneumococcus].
    Sánchez-Torrero JF; Fernández Capitán MC; Arnalich F; Díez Enciso M; Pacios E
    An Med Interna; 1992 Apr; 9(4):208-9. PubMed ID: 1581464
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of penicillin-resistant pneumococcal infections in adults].
    Falcó Ferrer V; Pahissa Berga A
    Rev Clin Esp; 2003 May; 203(5):244-7. PubMed ID: 12765573
    [No Abstract]   [Full Text] [Related]  

  • 39. Respiratory tract infection: epidemiology and surveillance.
    Jacobs MR
    J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-resistant Streptococcus pneumoniae infections: clinical importance, drug treatment, and prevention.
    Kellner JD
    Semin Respir Infect; 2001 Sep; 16(3):186-95. PubMed ID: 11562898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.